Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-08

Clinical Trial Update: Digoxin Drug-Drug Interaction With Lurasidone HCl [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the potential drug-drug interaction between digoxin and lurasidone hydrochloride in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DIGOXIN (Digoxin)
  • Lurasidone HCl (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED